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Abstract
Background: Due to the increasing incidence of basal cell 
carcinoma (BCC) and rising health care costs, health care in-
surance companies seek ways to shift skin surgery for BCC 
from secondary to primary care. Objectives: To study the dif-
ferences in complete excision of BCC by general practitio-
ners (GPs), dermatologists, and plastic surgeons. Methods: A 
retrospective cross-sectional study of pathology records of 
2,986 standard excisions of primary BCCs performed by a GP, 
dermatologist, or plastic surgeon in the area of Southwest 
Netherlands between 2008 and 2014. To compare the risk of 
an incomplete BCC excision between the specialties, the 
odds ratio (OR) was used adjusted for patient age, sex, tumor 
site, size, and histological subtype. Results: BCCs were com-
pletely excised by GPs in 70%, which was lower than the 93% 
by dermatologists and 83% by plastic surgeons (p < 0.001). 
Compared to the dermatologist, BCCs which were excised 
by a GP were 6 times higher at risk of an incomplete excision 
(adjusted OR 6, 95% CI 5–8) and 2 times higher at risk when 
excised by a plastic surgeon (adjusted OR 2, 95% CI 2–3). 
Conclusion: BCCs were more often completely excised by 
dermatologists than by GPs and plastic surgeons. Dermatol-
ogists probably perform better because of their extensive 
training and high experience in BCC care. To minimize in-
complete BCC excision, GPs should receive specific training 
before the shift of BCC care from secondary to primary care 
is justifiable. © 2018 The Author(s) 
Published by S. Karger AG, Basel
This article is licensed under the Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License (CC BY-
NC-ND) (http://www.karger.com/Services/OpenAccessLicense). 
Usage and distribution for commercial purposes as well as any dis-
tribution of modified material requires written permission.
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Introduction
Basal cell carcinoma (BCC) is the most common can-
cer in the Netherlands. According to the Netherlands 
Cancer Registry, the BCC incidence rate is about 40,000 
per year with an increase of 5% each year [1]. In the Neth-
erlands, patients initially visit a general practitioner (GP) 
for their skin lesions. The GPs decide whether to treat the 
patient themselves or to refer to a specialist. Although 
Dutch GPs are not specifically trained in skin tumor care 
(unlike counterparts in the UK and Australia), they do 
excise 27% of the benign skin tumors they encounter and 
31% of the skin tumors they suspect to be malignant [2, 
3]. If GPs refer a patient with a skin tumor, this is most 
often to a dermatologist or plastic surgeon, and less often 
to an ophthalmologist, general surgeon or ear-nose-and-
throat specialist. In the Netherlands, until June 2017, a 
specific BCC guideline for GPs was lacking, while special-
ists could refer to their multidisciplinary conducted 
Dutch BCC guideline since 2002. Adherence to guide-
lines, however, might vary within and between specialists, 
which may result in different treatment choices and qual-
ity of care. According to the Dutch BCC guideline, the 
first choice of treatment for BCC is a standard excision, 
with a clinical tumor-free excision margin of 3 mm for 
nonaggressive BCC subtypes (i.e., nodular and superfi-
cial) < 2 cm and a 5-mm margin for larger BCCs or BCCs 
with an aggressive histological subtype (i.e., infiltrative or 
micronodular) [4]. Incompletely excised BCCs need re-
excision to prevent recurrence, as recurrent BCCs can be 
more aggressive and therefore more difficult to treat, 
leading to impaired functional and cosmetic outcome for 
patients and higher costs for society.
Health insurance companies and governments world-
wide promote a shift of minor skin surgery from second-
ary to primary care in order to reduce health care costs 
[5–7]. Accordingly, the Dutch Collaborating Centre of 
the WHO promotes a shift of BCC care, even though it is 
unknown whether the quality of BCC care among GPs is 
sufficient compared to medical specialists. The quality of 
BCC care among GPs and medical specialists needs to be 
carefully assessed, as quality of care should not be com-
promised in order to reduce costs. One of the indicators 
for the quality of BCC care is the rate of completely ex-
cised BCCs. This retrospective cross-sectional study of 
pathology records compared the rate of completely ex-
cised BCCs between GPs, dermatologists, and plastic sur-
geons in the Netherlands. 
Exclusion criteria:
Recurrent BCC
Missing or unclear histological completeness/treatment
method/histological subtype/tumor site/treating medical
practitioner/patient age or sex
All biopsies and biopsies with the goal of complete
excision
Other treating medical practitioner (such as 
ophthalmologists, ENT specialists, general surgeons)
Inclusion criteria:
Primary BCC
Conventional excisions
by GP, dermatologist, plastic surgeon
PATHAN data
2008–2014
BCC excisions
231 GPs
931 BCCs
7 Jan. 2008 to 31 Dec. 2014
70% complete BCC excisions
22 dermatologists
1,015 BCCs
11 July 2014 to 31 Dec. 2014
93% complete BCC excisions
22 plastic surgeons
1,040 BCCs
4 Sep. 2013 to 31 Dec. 2014
83% complete BCC excisions
Fig. 1. Flowchart of Material and Methods.
Ramdas et al.Dermatology 2018;234:86–9188
DOI: 10.1159/000490344
Materials and Methods
For further details, see the online supplementary material (see 
www.karger.com/doi/10.1159/000490344 for all online suppl. ma-
terial) (Fig. 1).
Results
In total 2,986 pathology records of BCC excisions were 
included. The patients’ median age was 69 years (SD ±13 
years), and 52% were male. Of the 2,986 BCCs, 931 were 
excised by a GP (n = 231) in a period of 6 years, 1,015 by 
a dermatologist (n = 22) in a period of 6 months, and 
Table 1. A comparison of patient characteristics and number of complete basal cell carcinoma excisions between specialties, with sub-
divisions per site and histopathological subtype
GP, 
n (%)
DE, 
n (%)
PS, 
n (%)
Specialties 
combined, 
n (%)
GP, 
DE, PS
p value
GP vs. 
DE
p value
PS vs. 
DE
p value
Excisions, n 931 1,015 1,040 2,986
Physicians, n 231 22 22 275
Patients
Age (mean ± SD), years 67±13 70±12 69±14 69±13 <0.001 
Male 468 (50) 608 (60) 469 (45) 1,545 (52) <0.001 <0.001 <0.001
Complete excisions total 649 (70) 946 (93) 867 (83) 2,462 (82) <0.001 <0.001 <0.001
Per site
Head/neck 173 (56) 414 (89) 638 (80) 1,225 (78) <0.001 <0.001 <0.001
Trunk 299 (78) 356 (97) 126 (93) 781 (88) <0.001 <0.001 0.062
Limbs 177 (74) 176 (96) 103 (95) 458 (86) <0.001 <0.001 0.501
Per subtype
Nodular 305 (73) 441 (96) 386 (89) 1,132 (86) <0.001 <0.001 <0.001
Superficial 129 (81) 212 (94) 102 (92) 443 (90) <0.001 <0.001 0.417
Infiltrative 33 (45) 49 (88) 79 (69) 161 (66) <0.001 <0.001 0.008
Mixed nonagg.1 58 (67) 90 (90) 58 (74) 206 (78) 0.001 <0.001 0.006
Mixed agg.2 124 (64) 154 (89) 242 (80) 520 (78) <0.001 <0.001 0.015
Per site/per subtype
Head/neck
Nodular 112 (65) 238 (93) 323 (87) 673 (84) <0.001 <0.001 0.022
Superficial 3 (50) 31 (89) 28 (80) 62 (82) 0.075
Infiltrative 9 (24) 28 (82) 65 (65) 102 (59) <0.001 <0.001 0.058
Mixed nonagg. 6 (38) 32 (87) 35 (69) 73 (70) 0.002 <0.001 0.052
Mixed agg. 43 (56) 85 (83) 187 (78) 315 (75) <0.001 <0.001 0.334
Trunk
Nodular 143 (82) 143 (99) 34 (97) 320 (90) <0.001 <0.001 0.275
Superficial 62 (83) 134 (97) 44 (98) 240 (93) <0.001 <0.001 0.809
Infiltrative 19 (79) 15 (94) 8 (100) 42 (87) 0.198
Mixed nonagg. 27 (68) 31 (86) 14 (88) 72 (78) 0.089
Mixed agg. 48 (69) 33 (100) 26 (84) 107 (80) 0.001 <0.001 0.016
Limbs
Nodular 50 (69) 60 (98) 29 (97) 139 (85) <0.001 <0.001 0.604
Superficial 64 (82) 47 (90) 30 (97) 141 (88) 0.083
Infiltrative 5 (46) 6 (100) 6 (86) 17 (71) 0.036
Mixed nonagg. 25 (83) 27 (100) 9 (82) 61 (90) 0.076
Mixed agg. 33 (70) 36 (97) 29 (97) 98 (86) <0.001 0.001 0.880
Percentages were rounded. GP, general practitioner; DE, dermatologist; PS, plastic surgeon; nonagg., nonaggressive; agg., aggressive. 
1 Mixed nonaggressive basal cell carcinomas were superficial with nodular type (n = 264). 2 Mixed aggressive basal cell carcinomas 
(n = 668) were: superficial with infiltrative (n = 48), superficial with nodular and infiltrative (n = 67), nodular with infiltrative (n = 544), 
and infiltrative with micronodular type (n = 9).
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1,040 by a plastic surgeon (n = 22) in a period of 15 months 
(Table 1).
Overall, BCCs were completely excised in 82% 
(2,462/2,986) (Table 1). BCCs were completely excised by 
GPs in 70% (649/931), which was lower than the 93% 
(946/1,015) by dermatologists, and 83% (867/1,040) by 
plastic surgeons (p < 0.001). Compared to the dermatolo-
gist, BCCs which were excised by a GP were 6 times high-
er at risk of an incomplete excision (adjusted OR 6, 95% 
CI 5–8) and 2 times higher at risk when excised by a plas-
tic surgeon (adjusted OR 2, 95% CI 2–3) (p < 0.0001) (Ta-
ble 2). The risk of an incomplete excision was higher for 
small BCCs (adjusted OR 0.4, 95% CI 0.3–0.5, p < 0.0001). 
The risk of an incomplete BCC excision was not increased 
by patients’ age or sex.
BCCs of the Head and Neck
BCCs of the head and neck were completely excised 
in 78%, which was lower than the 88% of completely 
excised BCCs of the trunk and 86% of the limbs (Table 
1). The risk of an incomplete excision was higher for 
BCCs of the head and neck than for BCCs of the trunk 
and limbs (adjusted OR 3, 95% CI 2–4) (p < 0.0001) 
(Table 2). BCCs of the head and neck were completely 
excised by GPs in 56%, which was lower than the 89% 
for dermatologists and 80% for plastic surgeons (Table 
1). For the complete excision of a BCC of the head and 
neck, dermatologists performed better than GPs and 
plastic surgeons (p < 0.001). When BCCs of the head 
and neck were subdivided per histological subtype, GPs 
still showed the lowest proportion of complete excisions 
when compared to the dermatologists (p < 0.001 for 
each subtype), while differences between dermatolo-
gists and plastic surgeons were not significant (p > 
0.0125).
BCCs with an Infiltrative or Mixed Histological 
Subtype
Infiltrative BCCs were completely excised in 66%, 
which was lower than the 86% of nodular, 90% of super-
ficial, 78% of mixed nonaggressive, and 78% of mixed ag-
gressive BCCs (p < 0.001) (Table 1). 
Table 2. Risk of incomplete basal cell carcinoma (BCC) excision between specialties, adjusted for tumor and pa-
tient characteristics
Category Variable Univariable analysis Multivariable analysis
OR (95% CI) 
for incomplete 
BCC excision
p value OR (95% CI) 
for incomplete 
BCC excision
p value
Specialty Dermatologist
General practitioner 
Plastic surgeon
ref.
6.0 (4.5–7.9)
2.7 (2.0–3.7)
<0.0001
<0.0001
6.2 (4.6–8.4)
2.0 (1.5–2.7)
<0.0001
<0.0001
Tumor 
characteristics
Trunk
Head/neck
Limbs
≤2.5 cm 
>2.5 cm
Nodular
Superficial
Infiltrative
Mixed nonaggressive1 
Mixed aggressive2
ref.
2.1 (1.7–2.7)
1.2 (0.9–1.7)
Ref.
0.3 (0.2–0.4)
Ref.
0.7 (0.5–1.0)
3.2 (2.4–4.3)
1.7 (1.3–2.4)
1.8 (1.4–2.2)
<0.0001
0.248
<0.0001
0.055
<0.0001
<0.001
<0.0001
2.7 (2.0–3.6)
1.1 (0.8–1.5)
0.4 (0.3–0.5)
1.3 (0.9–1.9)
3.4 (2.4–4.7)
2.6 (1.8–3.7)
2.0 (1.6–2.6)
<0.0001
0.605
<0.0001
0.146
<0.0001
<0.0001
<0.0001
Patient 
characteristics
Male
Female
Age (for a difference of 1 year)
Ref.
1.1 (0.9–1.4)
1.0 (1.0–1.0)
0.207
0.074
1.0 (0.8–1.2)
1.0 (1.0–1.0)
0.768
0.069
Percentages were rounded. OR, odds ratio; CI, confidence interval; BCC, basal cell carcinoma. 1 Mixed non-
aggressive BCCs were superficial with nodular type (n = 264). 2 Mixed aggressive BCCs (n = 668) were: superficial 
with infiltrative (n = 48), superficial with nodular and infiltrative (n = 67), nodular with infiltrative (n = 544), and 
infiltrative with micronodular type (n = 9).
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The risk of an incomplete excision was higher for 
BCCs with the following histological subtypes: infiltrative 
(adjusted OR 3, 95% CI 2–5), mixed nonaggressive (ad-
justed OR 3, 95% CI 2–4), and mixed aggressive (adjusted 
OR 2, 95% CI 2–3) (p < 0.0001). Infiltrative BCCs were 
completely excised by GPs in 45%, which was lower than 
the 88% for dermatologists, and 69% for plastic surgeons. 
For the complete excision of an infiltrative BCC, derma-
tologists performed better than GPs and plastic surgeons 
(p < 0.0125). For both mixed nonaggressive and mixed 
aggressive subtypes, GPs had the lowest proportions of 
completely excised BCCs when compared to dermatolo-
gists and plastic surgeons. For the complete excision of 
mixed nonaggressive and mixed aggressive subtypes, der-
matologists performed better than GPs (p < 0.001).
Discussion
This retrospective cross-sectional study of 2,986 pa-
thology records from a Dutch regional laboratory, showed 
that primary BCCs were more often completely excised 
by a dermatologist (93%) than by a GP (70%) or plastic 
surgeon (83%). Compared to the dermatologist, BCCs 
which were excised by a GP were 6 times higher at risk of 
an incomplete excision (adjusted OR 6, 95% CI 5–8) and 
2 times higher at risk when excised by a plastic surgeon 
(adjusted OR 2, 95% CI 2–3) (p < 0.0001). 
Previous studies found similar proportions of com-
plete BCC excisions; however, these studies lack a sample 
size calculation, subgroup analyses per tumor site and 
histological subtype, and logistic regressions [8–11]. Der-
matologists probably excise BCC more often complete 
than GPs and plastic surgeons because dermatologists are 
specifically trained in BCC care during their 5 years of 
specialization, and dermatologists are more experienced 
in BCC care due to the high case load in their daily prac-
tice. This might result in better clinical skills among der-
matologists in recognizing skin lesions as suspected for 
BCC, and in demarcating the tumor preoperatively. Both 
skills contribute to the success of a complete BCC exci-
sion. 
The risk of an incomplete excision was found higher 
for BCCs of the head and neck than for BCCs of the trunk 
and limbs (adjusted OR 3, 95% CI 2–4) (p < 0.0001), ir-
respectively of the specialist who performed the excision. 
First, this could be explained because BCCs of the H zone 
are known to grow more aggressively. Second, physicians 
might narrow their excision margins for BCCs of the head 
and neck to preserve functional and cosmetic outcome.
The risk of an incomplete excision was found to be 
higher for BCCs with an infiltrative or mixed histological 
subtype than for nodular or superficial BCCs. Smeets et 
al. [12] showed that excisions with a clinical tumor-free 
margin of 3 mm for primary facial BCCs with an infiltra-
tive histological subtype were more often incomplete 
(25%) than other subtypes (12%, p < 0.05). These findings 
suggest that preoperative histological subtype determina-
tion might be useful to indicate when wider clinical tu-
mor-free excision margins are needed. Although in 1 out 
of 6 BCCs the most aggressive growth pattern is missed 
by the preoperative biopsy (i.e., sampling error), a biopsy 
was shown to be more sensitive and more specific than 
the clinical diagnosis on the histological subtype [13, 14]. 
Remarkably, the risk of an incomplete excision was 
found higher for small BCCs (i.e., ≤2 cm). The clinical 
demarcation of a small BCC might be more difficult due 
to scar formation after a preoperative biopsy.
Strengths of this study are: the comparative design, the 
large sample size and analysis per tumor site, and histo-
logical subtype. This study was limited to a retrospective 
design which implicated selection bias between the spe-
cialties. Therefore, risk of an incomplete BCC excision 
between the specialties was adjusted for BCC site, speci-
men size, histological subtype, patients’ age, and sex. But 
due to missing data, BCC localization in the H zone and 
exact clinical tumor size could not be specified. Also, it 
was unknown whether the BCC diagnosis was confirmed 
histologically prior to the excision and which excision 
margins were used. The real proportion of completely ex-
cised BCCs was overestimated in all groups due to miss-
ing tumor on the histological margins by applying the 
breadloaf technique.
In conclusion, this study shows that primary BCCs 
were more often completely excised by dermatologists 
than by GPs and plastic surgeons. Among GPs, complete 
excisions were specifically low for BCCs of the head and 
neck and BCCs with an infiltrative subtype. Dermatolo-
gists probably perform better because of their extensive 
training and high experience in BCC care. Before a shift 
of BCC care from secondary to primary care, there is a 
strong need for an integrated care pathway, including ad-
equate training for GPs.
Key Message
Basal cell carcinomas are more often completely excised by der-
matologists than by general practitioners or plastic surgeons.  
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